Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
17,700
+1,500 (9.26%)
At close: Apr 29, 2026
HNX:MKV Market Cap
HNX:MKV has a market cap or net worth of 88.5 billion as of May 18, 2026. Its market cap has increased by 90.32% in one year.
Market Cap
88.50B
Enterprise Value
49.59B
Revenue
152.40B
Ranking
n/a
PE Ratio
5.54
Stock Price
17,700.00
Market Cap Chart
Since January 9, 2009, HNX:MKV's market cap has increased from 9.90B to 88.50B, an increase of 793.94%. That is a compound annual growth rate of 13.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 88.50B | 17.22% |
| Dec 31, 2025 | 75.50B | 54.08% |
| Dec 27, 2024 | 49.00B | -9.26% |
| Dec 29, 2023 | 54.00B | -1.82% |
| Dec 5, 2022 | 55.00B | -20.86% |
| Dec 30, 2021 | 69.50B | -47.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imexpharm | 7.12T |
| Cuu Long Pharmaceutical JSC | 2.80T |
| OPC Pharmaceutical JSC | 1.49T |
| Vidipha Central Pharmaceutical JSC | 1.17T |
| Ben Tre Pharmaceutical JSC | 274.59B |
| Mediplantex National Pharmaceutical JSC | 228.34B |
| American Vietnamese Biotech Incorporation | 209.77B |
| Tipharco Pharmaceutical JSC | 146.96B |